Skip to main content
. 2016 Jan 28;22(4):1684–1700. doi: 10.3748/wjg.v22.i4.1684

Table 2.

Seroprevalence of hepatitis C virus infection in blood donors

S. # Year Place Method Sample size Seroprevalence (%) Ref.
1 2009 Mirpurkhas ELISA7 804 15.05 [25]
2 2010 Multan ELISA1 10000 4.90 [88]
3 2010 Peshawar ELISA7 32042 1.57 [92]
4 2011 KPK/FATA ELISA2 7148 1.89 [89]
5 2011 KPK/FATA ELISA2 62251 2.60 [91]
6 2011 Karachi -8 5717 1.90 [86]
7 2012 Karachi ELISA3 5517 2.00 [83]
8 2012 Peshawar ELISA2 127828 2.46 [84]
9 2012 Sargodha ELISA3 100 12.00 [85]
10 2013 Karachi MEIA/CLIA4 108598 2.61 [87]
11 2013 Quetta ELISA2 356 20.8 [27]
12 2013 Lahore ELISA5 245 15.00 [82]
13 2014 Karachi CLIA6 42830 1.65 [90]
1

Labkit Chemelex, Barcelona, Spain;

2

Biokit;

3

General Biologicals Corporation, Taiwan;

4

Abbott Diagnostics,

5

DiaSorin;

6

Ortho Clinical Diagnostics, NJ, United States;

7

Manufacturer not mentioned in cited reference;

8

Method not mentioned in cited reference. KPK: Khyber Pakhtunkhwa; FATA: Federally Administered Tribal Areas; ELISA: Enzyme linked immunosorbent assay; MEIA: Microparticle immunoassay; CLIA: Chemiluminescence immunoassay.